Literature DB >> 2954451

The role of atrial pressure in secreting atrial natriuretic polypeptides.

H Matsubara, M Nishikawa, Y Umeda, T Taniguchi, T Iwasaka, T Kurimoto, Y Yamane, M Inada.   

Abstract

The role of atrial pressure and catecholamines in secreting human atrial natriuretic polypeptides (hANP) were investigated in patients with acute or old myocardial infarction (AMI or OMI). No differences were observed in hANP levels obtained from brachial vein, right atrium, pulmonary artery and femoral artery, suggesting that hANP degradation in the pulmonary circulation has little clinical significance in hANP measurement. Plasma hANP levels in 10 patients with AMI were higher than those in controls and significantly correlated to both mean right atrial pressure (mRA) and pulmonary wedge pressure (PCW) (r = 0.76, p less than 0.05; r = 0.95; p less than 0.01, respectively). In 12 patients with OMI, plasma hANP levels were normal at rest and were significantly increased (p less than 0.01) with bicycle ergometer exercise associated with significant elevations of plasma catecholamine levels, mRA, and PCW. However, the increments of hANP correlated only to those of PCW. These results suggest that the elevation of atrial (principally left atrial) pressure rather than catecholamine stimulates hANP secretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2954451     DOI: 10.1016/0002-8703(87)90662-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Physiological hypertrophy of the heart and atrial natriuretic peptide during rest and exercise.

Authors:  J Svanegaard; K Angelo-Nielsen; J S Hansen
Journal:  Br Heart J       Date:  1989-12

Review 2.  Effects of exercise on atrial natriuretic factor. Release mechanisms and implications for fluid homeostasis.

Authors:  B J Freund; C E Wade; J R Claybaugh
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

3.  Changes in plasma atrial natriuretic peptide after angiocardiography.

Authors:  M Osada; S Takeda; R Ogawa; T Iida; K Umetani; T Sawanobori; H Ijiri; S Komori; K Tamura; K Kugiyama
Journal:  Exp Clin Cardiol       Date:  2001

4.  Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation.

Authors:  T Omland; V V Bonarjee; D W Nilsen; J A Sundsfjord; R T Lie; G Thibault; K Dickstein
Journal:  Br Heart J       Date:  1993-11

5.  Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.

Authors:  C Haug; A Metzele; J Steffgen; M Kochs; V Hombach; A Grünert
Journal:  Clin Investig       Date:  1994-06

6.  Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase.

Authors:  P A Phillips; J Sasadeus; G P Hodsman; J Horowitz; A Saltups; C I Johnston
Journal:  Br Heart J       Date:  1989-02

Review 7.  Can biomarkers help to diagnose early heart failure with preserved ejection fraction?

Authors:  Jaroslav Meluzín; Josef Tomandl
Journal:  Dis Markers       Date:  2015-01-31       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.